Phase- and epidemic region-adjusted estimation of the number of coronavirus disease 2019 cases in China.


Journal

Frontiers of medicine
ISSN: 2095-0225
Titre abrégé: Front Med
Pays: China
ID NLM: 101549428

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 12 03 2020
accepted: 14 03 2020
pubmed: 13 4 2020
medline: 16 5 2020
entrez: 13 4 2020
Statut: ppublish

Résumé

The outbreak of the coronavirus disease 2019 was first reported in Wuhan in December 2019 and gradually spread to other areas in China. After implementation of prevention and control measures, the estimation of the epidemic trend is needed. A phase- and region-adjusted SEIR model was applied for modeling and predicting the number of cases in Wuhan, Hubei Province and regions outside Hubei Province in China. The estimated number of infections could reach its peak in late February 2020 in Wuhan and Hubei Province, which is 55 303-84 520 and 83 944-129 312, respectively, while the epidemic peaks in regions outside Hubei Province in China could appear on February 13, 2020 with the estimated 13 035-19 108 cases. According to the estimation, the outbreak would abate in March and April all over China. Current estimation provided evidence for planned work resumption under stringent prevention and control in China to further support the fight against the epidemic. Nevertheless, there is still possibility of the second outbreak brought by the work resumption and population migration, especially from Hubei Province and high intensity cities outside Hubei Province. Strict prevention and control measures still need to be considered in the regions with high intensity of epidemic and densely-populated cities.

Identifiants

pubmed: 32279219
doi: 10.1007/s11684-020-0768-7
pii: 10.1007/s11684-020-0768-7
pmc: PMC7148426
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

199-209

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
J Theor Biol. 2004 Jul 7;229(1):119-26
pubmed: 15178190
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Theor Biol. 2009 Jul 7;259(1):165-71
pubmed: 19289133
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):4023-4028
pubmed: 28351976
Indoor Air. 2006 Dec;16(6):469-81
pubmed: 17100668
Math Biosci. 2013 Nov;246(1):47-54
pubmed: 24012502
Conf Proc IEEE Eng Med Biol Soc. 2005;2005:7470-3
pubmed: 17282008
Bull Math Biol. 2019 Nov;81(11):4343-4365
pubmed: 28466232
Cell Discov. 2020 Feb 24;6:10
pubmed: 32133152
Philos Trans R Soc Lond B Biol Sci. 2021 Jul 19;376(1829):20200265
pubmed: 34053269
Int J Infect Dis. 2020 Feb;91:264-266
pubmed: 31953166
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
J R Soc Interface. 2007 Feb 22;4(12):155-66
pubmed: 17254982
Philos Trans R Soc Lond B Biol Sci. 2019 Jun 24;374(1775):20180282
pubmed: 31056043
China CDC Wkly. 2020 Jan 31;2(5):79-80
pubmed: 34594812
J Clin Med. 2020 Feb 07;9(2):
pubmed: 32046137
J Theor Biol. 2015 Nov 7;384:33-49
pubmed: 26297316

Auteurs

Ruijie Chang (R)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Huwen Wang (H)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Shuxian Zhang (S)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Zezhou Wang (Z)

Department of Cancer Prevention, Shanghai Cancer Center, Fudan University, Shanghai, China.
Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200025, China.

Yinqiao Dong (Y)

Department of Environmental and Occupational Health, School of Public Health, China Medical University, Shenyang, 110122, China.

Lhakpa Tsamlag (L)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Xiaoyue Yu (X)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Chen Xu (C)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Yuelin Yu (Y)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Rusi Long (R)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Ning-Ning Liu (NN)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Qiao Chu (Q)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Ying Wang (Y)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Gang Xu (G)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Tian Shen (T)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Suping Wang (S)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Xiaobei Deng (X)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Jinyan Huang (J)

State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine (Shanghai), Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.

Xinxin Zhang (X)

Research Laboratory of Clinical Virology, National Research Center for Translational Medicine (Shanghai), Ruijin Hospital and Ruijin Hospital North Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. zhangx@shsmu.edu.cn.

Hui Wang (H)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. huiwang@shsmu.edu.cn.

Yong Cai (Y)

School of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. caiyong202028@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH